A new study recently published in the Journal of Clinical Oncology finds that obese patients diagnosed with pancreatic cancer have a two-three month shorter survival period than patients with normal body weight. Although pancreatic cancer remains once of the deadliest tumour types according to the American Cancer Society, there is growing evidence of the linkage between obesity and cancer. According to Eric Jacobs, strategic director of pharmacoepidemiology at the American Cancer Society, "the most important thing to know about obesity and pancreatic cancer is that maintaining a healthy weight throughout life can help lower the risk of every developing this highly fatal cancer"
To read more about this study, click here
Study mentioned: Yuan C et al. Prediagnostic body mass index and pancreatic cancer survival. J Clin Oncol. 2013 Oct 21 [Epub ahead of print] PMID: 24145341
No comments:
Post a Comment